HSDT - NASDAQ
Solana Company
$1.40
-5.4%Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
At a Glance
Live SnapshotSolana Company Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Solana Company Income Statement
HSDT • NASDAQ
| Solana Company Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||||
6M | 520K | 644K | 787K | 522K | 661K | 1.5M | 478K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
GROSS PROFIT | |||||||||||||
(500K) | (582K) | (583K) | (463K) | (298K) | (751K) | (910K) | (59K) | (17K) | (0.0) | (0.0) | (0.0) | (0.0) | |
5.5M | -62K | 61K | 324K | 224K | -90K | 586K | 419K | -17K | 0.0 | 0.0 | 0.0 | 0.0 | |
OPERATING INCOME | |||||||||||||
(26.6M) | (13.8M) | (12.5M) | (15.8M) | (18.4M) | (14M) | (24.6M) | (27.1M) | (22.8M) | (9.3M) | (9.8M) | (1.1M) | (8.5M) | |
(23.1M) | (10.1M) | (9.3M) | (10.6M) | (12.2M) | (9.4M) | (16.5M) | (17.2M) | (8.4M) | (5.7M) | (5.3M) | (894.2K) | (4.3M) | |
(3.5M) | (3.7M) | (2.9M) | (4.3M) | (6M) | (4.6M) | (8.1M) | (9.9M) | (14.4M) | (3.6M) | (4.5M) | (171.8K) | (4.3M) | |
-21.1M | -13.9M | -12.4M | -15.5M | -18.1M | -14.1M | -24M | -26.7M | -22.9M | -9.3M | -9.8M | -1.1M | -8.5M | |
PRE-TAX INCOME | |||||||||||||
(635K) | (17K) | (0.0) | (834K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (46.9K) | (176.5K) | (1.3K) | (0.0) | |
-635K | -17K | 257K | -834K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -46.9K | -156.4K | -1.3K | 0.0 | |
(0.0) | (64K) | (276K) | (938K) | (200K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-19.8M | 2.2M | 3.6M | 1.4M | 10K | -54K | 14.2M | -1.9M | -5.2M | 2.4M | -29.9K | -1.3K | 0.0 | |
-40.9M | -11.7M | -8.9M | -14.1M | -18.1M | -14.1M | -9.8M | -28.6M | -28M | -6.9M | -9.8M | -1.1M | -8.5M | |
NET INCOME | |||||||||||||
-40.9M | -11.7M | -8.9M | -14.1M | -18.1M | -14.1M | -9.8M | -28.6M | -28M | -6.9M | -9.8M | -1.1M | -8.5M |
SEC Filings
HSDT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 29, 2026 | May 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 22, 2026 | May 21, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 15, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 15, 2026 | May 15, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 24, 2026 | April 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 08, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 10, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 09, 2026 | April 09, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 31, 2026 | March 30, 2026 | 2026 |
Related Guides
Continue your HSDT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.